Manchester Metropolitan University and Cambridge Medical Technologies Limited
Lead Participant:
MANCHESTER METROPOLITAN UNIVERSITY
Abstract
To develop a new to market, wearable detection device, based on totally novel technology, for measuring Acute Coronary Syndrome biomarker concentrations without the need for blood vessel puncture, for constant, real-time monitoring of patients with cardiac disease.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| MANCHESTER METROPOLITAN UNIVERSITY | £298,403 | £ 199,930 |
Participant |
||
| CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED |
People |
ORCID iD |